These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 9294379)
1. Medication development and testing in children and adolescents. Current problems, future directions. Vitiello B; Jensen PS Arch Gen Psychiatry; 1997 Sep; 54(9):871-6. PubMed ID: 9294379 [TBL] [Abstract][Full Text] [Related]
2. Psychopharmacology for young children: clinical needs and research opportunities. Vitiello B Pediatrics; 2001 Oct; 108(4):983-9. PubMed ID: 11581454 [TBL] [Abstract][Full Text] [Related]
3. Developing methodologies for monitoring long-term safety of psychotropic medications in children: report on the NIMH conference, September 25, 2000. Greenhill LL; Vitiello B; Abikoff H; Levine J; March JS; Riddle MA; Capasso L; Cooper TB; Davies M; Fisher P; Findling RL; Fried J; Labellarte MJ; McCracken JT; McMahon D; Robinson J; Skrobala A; Scahill L; Varipatis E; Walkup JT; Zito JM J Am Acad Child Adolesc Psychiatry; 2003 Jun; 42(6):651-5. PubMed ID: 12921472 [TBL] [Abstract][Full Text] [Related]
4. Pediatric psychopharmacological research in the post EU regulation 1901/2006 era. Schmäl C; Becker K; Berg R; Brünger M; Lehmkuhl G; Oehler KU; Ruppert T; Staudter C; Trott GE; Dittmann RW Z Kinder Jugendpsychiatr Psychother; 2014 Nov; 42(6):441-9. PubMed ID: 25335522 [TBL] [Abstract][Full Text] [Related]
5. Psychopharmacology for children: from off label use to registration. Wohlfarth T; Kalverdijk L; Rademaker C; Schothorst P; Minderaa R; Gispen-de Wied C Eur Neuropsychopharmacol; 2009 Aug; 19(8):603-8. PubMed ID: 19428221 [TBL] [Abstract][Full Text] [Related]
7. Ethical and pragmatic issues in the use of psychotropic agents in young children. Jensen PS Can J Psychiatry; 1998 Aug; 43(6):585-8. PubMed ID: 9729685 [TBL] [Abstract][Full Text] [Related]
8. Ethical issues in child psychopharmacology research and practice: emphasis on preschoolers. Spetie L; Arnold LE Psychopharmacology (Berl); 2007 Mar; 191(1):15-26. PubMed ID: 17279378 [TBL] [Abstract][Full Text] [Related]
9. Research in child and adolescent psychopharmacology: recent accomplishments and new challenges. Vitiello B Psychopharmacology (Berl); 2007 Mar; 191(1):5-13. PubMed ID: 16718480 [TBL] [Abstract][Full Text] [Related]
10. Predictors of polypharmacy and off-label prescribing of psychotropic medications: a national survey of child and adolescent psychiatrists. Kearns MA; Hawley KM J Psychiatr Pract; 2014 Nov; 20(6):438-47. PubMed ID: 25406048 [TBL] [Abstract][Full Text] [Related]
11. Psychoactive medication prescribing practices for U.S. children: gaps between research and clinical practice. Jensen PS; Bhatara VS; Vitiello B; Hoagwood K; Feil M; Burke LB J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):557-65. PubMed ID: 10230187 [TBL] [Abstract][Full Text] [Related]
12. [Particularities and problems of psychopharmacology in childhood and adolescence]. Gerlach M; Renner T; Romanos M Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2023 Jul; 66(7):761-766. PubMed ID: 37277511 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic drug monitoring in child and adolescent psychiatry. Egberts KM; Mehler-Wex C; Gerlach M Pharmacopsychiatry; 2011 Sep; 44(6):249-53. PubMed ID: 21959786 [TBL] [Abstract][Full Text] [Related]
15. Ethical issues in psychopharmacology of children and adolescents. Koelch M; Schnoor K; Fegert JM Curr Opin Psychiatry; 2008 Nov; 21(6):598-605. PubMed ID: 18852568 [TBL] [Abstract][Full Text] [Related]
17. Child and adolescent psychopharmacology in the new millennium: a workshop for academia, industry, and government. Deveaugh-Geiss J; March J; Shapiro M; Andreason PJ; Emslie G; Ford LM; Greenhill L; Murphy D; Prentice E; Roberts R; Silva S; Swanson JM; VAN Zwieten-Boot B; Vitiello B; Wagner KD; Mangum B J Am Acad Child Adolesc Psychiatry; 2006 Mar; 45(3):261-270. PubMed ID: 16540810 [TBL] [Abstract][Full Text] [Related]
18. The National Institute of Mental Health-Psychotherapeutic Medications Development Program (PMDP): status 1993. Haigler HJ Psychopharmacol Bull; 1994; 30(1):19-22. PubMed ID: 7972624 [No Abstract] [Full Text] [Related]
19. Medicine. What are the right targets for psychopharmacology? Hyman SE; Fenton WS Science; 2003 Jan; 299(5605):350-1. PubMed ID: 12532001 [No Abstract] [Full Text] [Related]
20. AACAP 2002 research forum: placebo and alternatives to placebo in randomized controlled trials in pediatric psychopharmacology. March J; Kratochvil C; Clarke G; Beardslee W; Derivan A; Emslie G; Green EP; Heiligenstein J; Hinshaw S; Hoagwood K; Jensen P; Lavori P; Leonard H; McNulty J; Michaels MA; Mossholder A; Osher T; Petti T; Prentice E; Vitiello B; Wells K J Am Acad Child Adolesc Psychiatry; 2004 Aug; 43(8):1046-56. PubMed ID: 15266201 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]